Abstract:Research ethics: Not applicable. Informed consent: Not applicable. Author contributions: All authors contributed with analysis and interpretation of data, provided intellectual content of critical importance to the work described, revising the article and have accepted responsibility for the entire content of this manuscript and approved its submission. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: The raw data can be obtained on request from the corresponding author. 1. Mollison, PL, Walker, W. Controlled trials of the treatment of hemolytic disease of the newborn. Lancet 1952;1:429–33. https://doi.org/10.1016/s0140-6736(52)91949-1. Search in Google Scholar PubMed 2. Cortey, A. Kernicterus: the comeback. Arch Pediatr 2012;19:897–9. https://doi.org/10.1016/j.arcped.2012.06.018. Search in Google Scholar PubMed 3. Bhutani, VK, Johnson, L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol 2009;29(Supplement 1):S61–7. https://doi.org/10.1038/jp.2008.213. Search in Google Scholar PubMed 4. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia . Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004; 114:1138]. Pediatrics 2004;114:297–316. https://doi.org/10.1542/peds.114.1.297. Search in Google Scholar PubMed 5. Mailloux, A. What to expect from a bilirubin analysis for management of Jaundiced Newborns? Clin Biochem 2014;47:751–2. https://doi.org/10.1016/j.clinbiochem.2014.05.043. Search in Google Scholar PubMed 6. Cobbaert, C, Weykamp, C, Hulzebos, CV. Bilirubin standardization in The Netherlands: alignment within and between manufacturers. Clin Chem 2010;56:872–3. https://doi.org/10.1373/clinchem.2009.142059. Search in Google Scholar PubMed 7. Mailloux, A, Cortey, A, Delatour, V, Poupon, C, Rota, M, Schmitt, F, et al.. Recommandations analytiques et cliniques pour l'utilisation de la bilirubinémie en néonatalogie. Ann Biol Clin 2020;78:383–97. https://doi.org/10.1684/abc.2020.1571. Search in Google Scholar PubMed 8. Vaubourdolle, M, Mailloux, A. Intérêt de la bilirubinémie en néonatalogie : recommandations pour une utilisation coordonnée par le LBM de la biologie délocalisée et des tests rapides d'orientation diagnostique. Ann Biol Clin 2022;80:509–19. https://doi.org/10.1684/abc.2022.1774. Search in Google Scholar PubMed 9. Thomas, M, Greaves, RF, Tingay, DG, Loh, TP, Ignjatovic, V, Newall, F, et al.. Current and emerging technologies for the timely screening and diagnosis of neonatal jaundice. Crit Rev Clin Lab 2022;59:332–52. https://doi.org/10.1080/10408363.2022.2038074. Search in Google Scholar PubMed © 2024 Walter de Gruyter GmbH, Berlin/Boston

Knowledge management approach in build-to-order supply chains

Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.

Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study

Neurodevelopmental outcome at 6 months of age of full-term neonates with hyperbilirubinemia necessitating exchange transfusion

Developmental outcome of neonates underwent exchange transfusion due to hyperbilirubinemia: A single-center experience

Effects of mutationally activated Ha‐ras on c‐fos expression kinetics in rat tracheal epithelial cells

An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.

Clinical Features of 116 Near Term and Term Infants with Acute Bilirubin Encephalopathy in Eastern China

[Effect and Safety of Intensive Phototherapy in Treatment of Neonatal Hyperbilirubinemia].

Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial

Technical Report: Diagnosis and Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.

Issues for standardization of neonatal bilirubinemia: a case of delayed phototherapy initiation

Communication: Cross-cultural applications of the physician's art.

Hematological abnormality and associated factors in newborns with hyperbilirubinemia before and after phototherapy at University of Gondar Comprehensive Specialized Hospital

Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation: Technical Report

Bilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline

Outcome of exchange blood transfusions done for neonatal jaundice in Abakaliki, South Eastern Nigeria

Effectiveness of phototherapy with and without probiotics for the treatment of indirect hyperbilirubinaemia in preterm neonates: a randomised controlled trial

Efficacy of Intermittent Phototherapy versus Continuous Phototherapy for Treatment of Neonatal Hyperbilirubinaemia: A Systematic Review and Meta‐analysis

Understanding the Risk Factors for Adverse Events During Exchange Transfusion in Neonatal Hyperbilirubinemia Using Explainable Artificial Intelligence